Table 2 Clinical details
UC Total | UC Rem | UC Res | UC NRes | Control | |
|---|---|---|---|---|---|
Characteristics | n = 38 | n = 19 | n = 9 | n = 10 | n = 37 |
Gender (male/female) | 18/20 | 9/10 | 4/5 | 5/5 | 18/19 |
Age, years (mean, range) | 39 (20–66) | 41 (20–66) | 38 (23–65) | 37 (21–54) | 42 (26–63) |
Age at diagnosis (≤25/> 25 years) | 15/23 | 5/14 | 4/5 | 6/4 | – |
Years with disease (≤10/> 10 years) | 24/14 | 10/9 | 6/3 | 8/2 | – |
Mayo-score (mean, range) | 7 (3–12) | 6 (3–12) | 8 (6–11) | 7 (5–10) | – |
Extension (P, PS, LC, PC) | 2/8/5/23 | 1/7/1/10 | 0/1/1/7 | 1/0/3/6 | – |
Surgery/no surgery | 2/36 | 1/18 | 0/9 | 1/9 | – |
Smoking/non-smoking | 2/36 | 1/18 | 1/8 | 0/10 | 0/37 |
EIM (present/not present) | 0/38 | 0/19 | 0/9 | 0/10 | – |
Steroids, n | – | ||||
Independent/dependent/responder | 1/32/5 | 1/17/1 | 0/8/1 | 0/7/3 | – |
Daily medication, n | – | ||||
Systemic 5-aminosalicylic acid (1.6–3.2 g) | 29 | 13 | 7 | 9 | – |
Topical 5-aminosalicylic acid (1 g) | 1 | 1 | 0 | 0 | – |
Systemic glucocorticoids (75 mg)a | 18 | 9 | 4 | 5 | – |
Topical glucocorticoids (100 mg) | 1 | 1 | 0 | 0 | – |
Azathioprine (100–150 mg) | 25 | 14 | 5 | 5 | – |
None | 0 | 0 | 0 | 0 | 37 |